Another signaling pathway involved in regulating the activity of breast cancer stem cells is PI3K/Akt, since Akt downregulates glycogen synthetase kinase 3β (GSK3β) by phosphorylation in the Ser9 residue, thus stabilizing β-catenin. This evidence concerns the gene AKT1 and breast carcinoma.